/Companies

Trishula Therapeutics, Inc.

8 employees on LinkedIn · 4 known investors

Find your way into Trishula Therapeutics, Inc.

Sign up to see every warm intro you have to Trishula Therapeutics, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Trishula Therapeutics, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers. It focuses on oncology and immunotherapy drug development.

Founders & leadership

ASAnil Singhal
Anil SinghalPresident and CEO
SMSiddhartha Mitra
Siddhartha MitraChief Medical Officer

Investors · 4

Related companies · 2

Companies working in the same space as Trishula Therapeutics, Inc..

In the news

Frequently asked questions

What does Trishula Therapeutics, Inc. do?
Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers. It focuses on oncology and immunotherapy drug development.
Who are Trishula Therapeutics, Inc.'s investors?
Trishula Therapeutics, Inc.'s investors include Canaan Partners, MPM BioImpact, Astellas Venture Management LLC, Lightstone Ventures.